During the past decade, QualTex Laboratories conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "QualTex Laboratories" #1 collaborator was "MP Biomedicals Asia Pacific Pte. Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "QualTex Laboratories" are "Healthy" (2 trials), "HTLV I Associated Myelopathies" (1 trials), "HTLV I Associated T Cell Leukemia Lymphoma" (1 trials), "HTLV-I Infections" (1 trials) and "HTLV-II Infections" (1 trials). Many other conditions were trialed in "QualTex Laboratories" in a lesser frequency.

Most popular intervention types in "QualTex Laboratories" are "Device" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Alinity s Anti-HBc Assay" (1 trials), "Alinity s Anti-HCV Assay" (1 trials), "Alinity s Anti-HCV II" (1 trials), "Alinity s Chagas Assay" (1 trials) and "Alinity s HBsAg and Alinity s HBsAg Confirmatory Assay" (1 trials). Other intervention names were less common.

The vast majority of trials in "QualTex Laboratories" are 3 trials for "All" genders.

Currently, there are NaN active trials in "QualTex Laboratories". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in QualTex Laboratories, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in QualTex Laboratories, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".